Article

How Epidemiology Has Contributed to a Better Understanding of Skin Disease

Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands.
Journal of Investigative Dermatology (Impact Factor: 6.37). 12/2011; 132(3 Pt 2):994-1002. DOI: 10.1038/jid.2011.372
Source: PubMed

ABSTRACT Epidemiology literally means "the study of what is upon the people." It puts the individual's condition in a population context and is the path to disease prevention. In the first part of this review, important aspects of epidemiology are discussed. Fundamentals of epidemiologic research include the measurement of occurrence of an event (prevalence and incidence) and the identification of factors that are associated with this event. The main study designs in observational studies are cohort, case-control, and cross-sectional studies, all of which have intrinsic strengths and limitations. These limitations include a variety of biases, which can be regrouped into selection bias, information bias, and confounding. The STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) checklist is an important tool to further improve the reporting and quality of epidemiologic studies, and it is introduced. In the second part of this review, practical examples are presented, illustrating how dermatoepidemiology has contributed to an improved understanding of skin diseases and patient care, specifically in the case of melanoma therapy, serious cutaneous adverse reactions, Lyme disease, long-term safety of psoralin plus UVA (PUVA), teratogenicity of isotretinoin, and comorbidities in psoriasis.

Download full-text

Full-text

Available from: Tamar Nijsten, May 14, 2014
0 Followers
 · 
124 Views
  • Journal of Investigative Dermatology 03/2012; 132(3 Pt 2):747-50. DOI:10.1038/jid.2011.475 · 6.37 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Psoriasis vulgaris is a chronic, debilitating skin disease that affects millions of people worldwide. There is no mouse model that accurately reproduces all facets of the disease, but the accessibility of skin tissue from patients has facilitated the elucidation of many pathways involved in the pathogenesis of psoriasis and highlighted the importance of the immune system in the disease. The pathophysiological relevance of these findings has been supported by genetic studies that identified polymorphisms in genes associated with NFκB activation, IL-23 signaling and T helper 17 (Th17)-cell adaptive immune responses, and in genes associated with the epidermal barrier. Recently developed biologic agents that selectively target specific components of the immune system are highly effective for treating psoriasis. In particular, emerging therapeutics are focused on targeting the IL-23-Th17-cell axis, and several agents that block IL-17 signaling have shown promising results in early-phase clinical trials. This review discusses lessons learned about the pathogenesis of psoriasis from mouse-and patient-based studies, emphasizing how the outcomes of clinical trials with T-cell-targeted and cytokine-blocking therapies have clarified our understanding of the disease.
    Disease Models and Mechanisms 07/2012; 5(4):423-33. DOI:10.1242/dmm.009092 · 5.54 Impact Factor
  • Journal of Investigative Dermatology 06/2014; 134(6):1491-2. DOI:10.1038/jid.2014.72 · 6.37 Impact Factor